Switch to:
More From Other Websites
GSK eyes prime FTSE 100 slot for standalone HIV drugs business Oct 22 2014
Can Valeant's Strong Q3 Entice Allergan? Oct 20 2014
Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet Oct 20 2014
3 Stocks Reiterated As A Buy: PFE, MU, CELG Oct 20 2014
ViiV Healthcare Expands Program to Reduce HIV Disparities in Southern U.S. Oct 20 2014
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse Oct 17 2014
FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride)... Oct 17 2014
Pfizer Loses a Bet on Removing Serious Warnings From its Chantix Pill Oct 17 2014
[$$] Panel Votes to Keep Strong Warning on Smoking-Cessation Drug Oct 17 2014
FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
FDA panel votes to keep severe warning on Pfizer anti-smoking drug Oct 16 2014
FDA votes to keep black box warning on Pfizer anti-smoking drug Oct 16 2014
The Best-Selling Biologic Drugs Oct 16 2014
Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals Oct 16 2014
[video] S&P 500: When Will the Selling Stop? Oct 16 2014
BUZZ-Healthcare sector: Investors shooting from the hip Oct 16 2014
AbbVie recommends stockholders to reject Shire deal Oct 15 2014
AbbVie recommends stockholders to reject Shire deal Oct 15 2014
Shire Falls, AbbVie Questioned On Buyout Backtrack Oct 15 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 4 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK